Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aubree Gordon

Showing results (21-30 of 158) with videos related to

Pageof 16
Sort By:
Microbiome|June 17, 2023
CRISPR arrays as high-resolution markers to track microbial transmission during influenza infectionLingdi Zhang, Jahan Rahman, Matthew Chung, et al.
BMC Infectious Diseases|November 11, 2015
The Nicaraguan pediatric influenza cohort study: design, methods, use of technology, and complianceAubree Gordon, Guillermina Kuan, William Aviles, et al.
The American Journal of Tropical Medicine and Hygiene|December 9, 2015
Clinical Attack Rate of Chikungunya in a Cohort of Nicaraguan ChildrenAngel Balmaseda, Aubree Gordon, Lionel Gresh, et al.
Vaccine|October 8, 2017
Association between Haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015Sophia Ng, Saira Saborio, Guillermina Kuan, et al.
Cell Reports. Medicine|August 29, 2024
Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine boosterQian Wang, Ian A Mellis, Yicheng Guo, et al.
The Pediatric Infectious Disease Journal|September 3, 2010
Severe coinfections of dengue and pandemic influenza A H1N1 virusesMaria Angeles Perez, Aubree Gordon, Felix Sanchez, et al.
Virology|May 3, 2008
Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue feverAnna P Durbin, Maria José Vargas, Kimberli Wanionek, et al.
Science (New York, N.Y.)|November 4, 2017
Antibody-dependent enhancement of severe dengue disease in humansLeah C Katzelnick, Lionel Gresh, M Elizabeth Halloran, et al.
Cell Host & Microbe|February 20, 2024
XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1Qian Wang, Yicheng Guo, Anthony Bowen, et al.
Cell Reports|February 9, 2022
Long-term, infection-acquired immunity against the SARS-CoV-2 Delta variant in a hamster modelPeter J Halfmann, Makoto Kuroda, Tammy Armbrust, et al.
Pageof 16

Showing results (21-30 of 158) with videos related to

Sort By:
Pageof 16
Microbiome|June 17, 2023
CRISPR arrays as high-resolution markers to track microbial transmission during influenza infectionLingdi Zhang, Jahan Rahman, Matthew Chung, et al.
BMC Infectious Diseases|November 11, 2015
The Nicaraguan pediatric influenza cohort study: design, methods, use of technology, and complianceAubree Gordon, Guillermina Kuan, William Aviles, et al.
The American Journal of Tropical Medicine and Hygiene|December 9, 2015
Clinical Attack Rate of Chikungunya in a Cohort of Nicaraguan ChildrenAngel Balmaseda, Aubree Gordon, Lionel Gresh, et al.
Vaccine|October 8, 2017
Association between Haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015Sophia Ng, Saira Saborio, Guillermina Kuan, et al.
Cell Reports. Medicine|August 29, 2024
Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine boosterQian Wang, Ian A Mellis, Yicheng Guo, et al.
The Pediatric Infectious Disease Journal|September 3, 2010
Severe coinfections of dengue and pandemic influenza A H1N1 virusesMaria Angeles Perez, Aubree Gordon, Felix Sanchez, et al.
Virology|May 3, 2008
Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue feverAnna P Durbin, Maria José Vargas, Kimberli Wanionek, et al.
Science (New York, N.Y.)|November 4, 2017
Antibody-dependent enhancement of severe dengue disease in humansLeah C Katzelnick, Lionel Gresh, M Elizabeth Halloran, et al.
Cell Host & Microbe|February 20, 2024
XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1Qian Wang, Yicheng Guo, Anthony Bowen, et al.
Cell Reports|February 9, 2022
Long-term, infection-acquired immunity against the SARS-CoV-2 Delta variant in a hamster modelPeter J Halfmann, Makoto Kuroda, Tammy Armbrust, et al.
Pageof 16